Table 3.
Variables |
AKI+ (n=25) |
AKI− (n=177) |
P Value |
---|---|---|---|
KDIGO stage, No. (%) | |||
Stage 1 | 23 (92.0) | ||
Stage 2 | 2 (8.0) | ||
Continuous renal replacement therapy, No. (%) | 1 (4.0) | ||
Delta creatinine from baseline, mg/dL | 0.43 (0.38–0.56) | 0.10 (0.03–0.19) | <0.001 |
Creatinine increase from baseline, No. (%) | 60 (49–66) | 12 (4–24) | <0.001 |
Intubation time, h | 17 (15–21) | 7 (5–16) | <0.001 |
ICU stay, d | 4.0 (2.6–5.8) | 2.8 (1.8–3.8) | 0.010 |
Postoperative hospital stay, d | 28 (20–39) | 21 (16–27) | 0.024 |
Hospital mortality, No. (%) | 0 (0) | 0 (0) | 1.00 |
AKI indicates acute kidney injury; ICU, intensive care unit; and KDIGO, Kidney Disease: Improving Global Outcomes.